Deverick J. Anderson, a leading epidemiologist, receives the 2016 Distinguished Scientist Award from APIC for his significant and sustained contributions to infection prevention science. He is recognized for exemplifying scholarly excellence and infection prevention leadership within the scientific community.
A follow-up analysis of the ACCORD Trial found that people with type 2 diabetes who intensively controlled their blood sugar level had cut their risk of diabetic retinopathy in half. The study, supported by the National Eye Institute, suggests that well-controlled glycemia has a positive and lasting effect on eye health.
A global study found that patients with type 2 diabetes admitted to the hospital for congestive heart failure face a high risk of mortality, highlighting the need for increased attention to this critical condition. The study suggests that heart failure outcomes should receive equal scrutiny as other cardiovascular events in future rese...
A study presented at the APIC Annual Conference found that three-quarters of ED patients treated with antibiotics tested negative for gonorrhea or chlamydia. The research highlights the need to find a balance between treating patients and preventing unnecessary antibiotic use, which contributes to antibiotic resistance.
Researchers have discovered that adults born in the 1940s with diabetes are living longer and with less disability, performing day-to-day tasks, compared to those born a decade earlier. This trend is attributed to improvements in diabetes management and healthy lifestyle choices.
A new study shows that the innovative OnTouch Via patch enabled over 50% of diabetes patients to report improved insulin dose compliance. The wearable patch allows for discreet delivery of rapid-acting insulin at mealtimes, reducing stress and anxiety associated with dosing.
A Penn Medicine study found that individuals with acute insomnia who self-restrict their time in bed are less likely to develop chronic insomnia. This natural tendency can be an effective strategy for managing insomnia and even serves as part of cognitive behavioral therapy for chronic insomnia.